111 related articles for article (PubMed ID: 8262694)
1. 2-Buten-4-olide (2-B4O) inhibits type II collagen-induced arthritis in Lewis rats.
Takeoka Y; Naiki M; Taguchi N; Imai H; Kurimoto Y; Morita S; Suehiro S
Int J Immunopharmacol; 1993 Oct; 15(7):803-10. PubMed ID: 8262694
[TBL] [Abstract][Full Text] [Related]
2. 2-Buten-4-olide (2-B4O) inhibits experimental allergic encephalomyelitis (EAE) in Lewis rats.
Naiki M; Takeoka Y; Yago H; Kurimoto Y; Gershwin ME; Suehiro S
J Autoimmun; 1995 Oct; 8(5):727-39. PubMed ID: 8579727
[TBL] [Abstract][Full Text] [Related]
3. Physiological significance of 2-buten-4-olide (2-B4O), an endogenous satiety substance increased in the fasted state.
Oomura Y; Aou S; Matsumoto I; Sakata T
Exp Biol Med (Maywood); 2003 Nov; 228(10):1146-55. PubMed ID: 14610253
[TBL] [Abstract][Full Text] [Related]
4. Effects of the short chain sugar acid 2-buten-4-olide on the hypothalamo-pituitary-adrenal axis in normal and adjuvant-induced arthritic rats.
Kawasaki M; Onaka T; Saito J; Hashimoto H; Suzuki H; Otsubo H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
J Neuroendocrinol; 2007 Jan; 19(1):54-65. PubMed ID: 17184486
[TBL] [Abstract][Full Text] [Related]
5. Effect of an endogenous satiety substance, 2-buten-4-olide, on gastric acid secretion and experimental ulceration in rats.
Arai I; Usuki-Ito C; Muramatsu M; Otomo S; Shiraishi T; Oomura Y
Physiol Behav; 1990 Jan; 47(1):197-202. PubMed ID: 2326336
[TBL] [Abstract][Full Text] [Related]
6. The endogenous feeding suppressant, 2-buten-4-olide, impairs the pulsatile secretion of luteinizing hormone through endogenous opioid peptides.
Kaji H; Saito S; Shitsukawa K; Irahara M; Aono T
Eur J Endocrinol; 1998 Feb; 138(2):198-205. PubMed ID: 9506867
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2-buten-4-olide, an endogenous satiety substance, on plasma glucose, corticosterone, and catecholamines.
Matsumoto I; Oomura Y; Nishino H; Nemoto S; Aou S; Aikawa T
Am J Physiol; 1994 Feb; 266(2 Pt 2):R413-8. PubMed ID: 8141398
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII).
Waksman Y; Hod I; Friedman A
Clin Exp Immunol; 1996 Mar; 103(3):376-83. PubMed ID: 8608634
[TBL] [Abstract][Full Text] [Related]
10. 2-Buten-4-Olide (2-B4O) suppresses feeding in neonate and developing rat pups.
Mathur R
Physiol Behav; 2010 Sep; 101(2):232-6. PubMed ID: 20493892
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
[TBL] [Abstract][Full Text] [Related]
12. Induction of Fos-like immunoreactivity in the rat hypothalamus by an endogenous feeding suppressant (2-buten-4-olide).
Hisano S; Uemura N; Fukui Y; Miki M; Zhang R
Neurosci Lett; 1994 Nov; 182(1):80-2. PubMed ID: 7891895
[TBL] [Abstract][Full Text] [Related]
13. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
Phadke K; Carroll J; Nanda S
Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443
[TBL] [Abstract][Full Text] [Related]
14. Region-related Fos expression in hypothalamic dopaminergic neurons of rats by intraperitoneal administration of an endogenous satiety substance, 2-buten-4-olide.
Hisano S; Zhang R; Uemura N; Fukui Y; Miki T
Brain Res; 1995 Apr; 676(2):409-12. PubMed ID: 7614014
[TBL] [Abstract][Full Text] [Related]
15. The short chain sugar acid, 2-buten-4-olide, activates oxytocin-secreting neurons but not arginine vasopressin-secreting neurons in the hypothalamus of rats.
Kawasaki M; Yamaga C; Onaka T; Saito J; Mera T; Hashimoto H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
Brain Res; 2006 May; 1086(1):133-41. PubMed ID: 16616049
[TBL] [Abstract][Full Text] [Related]
16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
17. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen.
Yoshino S; Quattrocchi E; Weiner HL
Arthritis Rheum; 1995 Aug; 38(8):1092-6. PubMed ID: 7639805
[TBL] [Abstract][Full Text] [Related]
18. Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, inhibits the development of collagen-induced arthritis in mice.
Omata T; Segawa Y; Tamaki H; Fujisaku A; Koike T
Biol Pharm Bull; 1997 Jun; 20(6):694-7. PubMed ID: 9212993
[TBL] [Abstract][Full Text] [Related]
19. The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats.
Yoshino S
Exp Mol Pathol; 1995 Apr; 62(2):123-30. PubMed ID: 8549696
[TBL] [Abstract][Full Text] [Related]
20. Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen.
Cremer MA; Hernandez AD; Townes AS; Stuart JM; Kang AH
J Immunol; 1983 Dec; 131(6):2995-3000. PubMed ID: 6196409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
